COVID-19 vaccination in Eswatini

COVID-19 vaccination in Eswatini
DateMarch 19, 2021 (2021-03-19) – present
LocationEswatini
CauseCOVID-19 pandemic
MotiveCOVID-19 pandemic in Eswatini

COVID-19 vaccination in Eswatini is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

Eswatini began its vaccination program on 19 March 2021. In early May 2021, it was reported that Eswatini had administered all of the doses it had so far received.[1]

Background

History

Timeline

March 2021

  • March 2021: Eswatini receives 20,000 of the Oxford-AstraZeneca/Covishield vaccine, donated by India, and 12,000 doses of the same vaccine through COVAX.
  • 19 March 2021: launch of targeted vaccination campaign.
  • By the end of March, 9,871 vaccine doses had been administered.

April 2021

  • By the end of April, 34,897 vaccine doses had been administered.

May 2021

  • By the end of May, 34,897 vaccine doses had been administered.

June 2021

  • By the end of June, 34,897 vaccine doses had been administered.

July 2021

  • 27 July 2021: Eswatini receives 300,000 doses of the Janssen COVID-19 vaccine donated by the United States.
  • By the end of July, 66,553 vaccine doses had been administered and 27,227 persons fully vaccinated (6% of the targeted population).

August 2021

  • 3 August 2021: launch of general vaccination campaign.
  • By the end of August, 189,424 vaccine doses had been administered and 150,535 persons fully vaccinated (32% of the targeted population).

September 2021

  • By the end of September, 248,985 vaccine doses had been administered and 210,432 persons fully vaccinated (45% of the targeted population).

October 2021

  • By the end of October, 274,379 vaccine doses had been administered and 235,360 persons fully vaccinated (50% of the targeted population).

November 2021

  • By the end of November, 306,445 vaccine doses had been administered and 260,763 persons fully vaccinated (56% of the targeted population).

December 2021

  • By the end of December, 401,306 vaccine doses had been administered and 302,304 persons fully vaccinated (64% of the targeted population).

January 2022

  • By the end of December, 460,130 vaccine doses had been administered and 328,701 persons fully vaccinated (67% of the targeted population).

Progress

27,226 persons had been fully vaccinated by the end of July 2021, 150,535 by the end of August, 210,432 by the end of September, 235,360 by the end of October, and 260,763 (56% of the target population) by the end of November 2021.

Cumulative vaccinations in Eswatini[2]

References

  1. ^ McKenzie, David; Formanek, Ingrid (8 May 2021). "Countries in Africa fear they could become the next India as vaccine supplies dwindle". CNN. Retrieved 8 May 2021.
  2. ^ "owid/covid-19-data". GitHub. Retrieved 7 March 2021.


Media files used on this page

SARS-CoV-2 (Wikimedia colors).svg
Author/Creator: Geraki, Licence: CC BY-SA 4.0
SARS-CoV-2 logo in Wikimedia colors
SARS-CoV-2 (CDC-23312).png
This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV). Note the spikes that adorn the outer surface of the virus, which impart the look of a corona surrounding the virion, when viewed electron microscopically. This virus was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China.